Advanced Malignant Tumors Clinical Trial
Official title:
A Phase I, Open-label, Multicenter, Dose Escalation and Expansion Study to Evaluate the Tolerance and Pharmacokinetics of TQB3804 in Subjects With Advanced Malignant Tumors
This is a study to evaluate the tolerance, dose-limiting toxicity (DLT), phase II recommended dose (RP2D), and maximum tolerated dose (MTD) of single and multiple oral doses of TQB3804 in patients with advanced malignant tumors.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05082545 -
Phase I Study of SHR-2002 + SHR-1316 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05229497 -
A Phase Ib/II Study of AK112 in Combination With AK117 in Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT06223841 -
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05728541 -
Dose Escalation and Expansion Study of SYH2043 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05354076 -
Study on the Correlation Between Immunoglobulin and Liposomal Doxorubicin in Vivo
|
Phase 2 | |
| Recruiting |
NCT05868876 -
A Phase Ia/Ib Open Label，Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy of AK127 in Combination With AK104 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05991583 -
A Clinical Trial to Evaluate Effect of IBB0979 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05396391 -
A Clinical Trial to Evaluate Effect of IAP0971 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05235542 -
A Phase Ib/II Study of AK104 and AK117 in Combination With or Without Chemotherapy in Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05110807 -
A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05214482 -
A Study of AK112 in Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Not yet recruiting |
NCT05653284 -
A Study of AK130 in Patients With Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT05223231 -
Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Enrolling by invitation |
NCT05198817 -
A Trial of SHR-2002 Injection or Combined With Other Anti-cancer Medication in Advanced Malignant Tumors of Patients
|
Phase 1 | |
| Active, not recruiting |
NCT05193721 -
A Clinical Study of the Safety and Tolerability of SHR-1901 in Subjects With Advanced Malignant Tumors
|
Phase 1 | |
| Not yet recruiting |
NCT06226363 -
Phase I Study of LNF1901 in Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT06167486 -
SG2918 For Advanced Malignant Tumors
|
Phase 1 | |
| Recruiting |
NCT04980690 -
Clinical Trial of IBC0966 in Patients With Advanced Malignant Tumors
|
Phase 1/Phase 2 | |
| Recruiting |
NCT05877924 -
A Study of NBL-020 Injection in Subjects With Advanced Malignant Tumors.
|
Phase 1 | |
| Active, not recruiting |
NCT04708210 -
Study of the Efficacy and Safety of IBI319 in Patients With Advanced Malignant Tumors
|
Phase 1 |